Vabysmo vs Tepezza
A side-by-side look at two eye health medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Vabysmo | US Tepezza |
|---|---|---|
| Generic name | faricimab-svoa Unverified catalogue summary (Generic name) for Vabysmo in US; not checked against current local product information. | teprotumumab-trbw Unverified catalogue summary (Generic name) for Tepezza in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Vabysmo in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Tepezza in US; not checked against current local product information. |
| Treats | Wet macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion Unverified catalogue summary (Treats) for Vabysmo in US; not checked against current local product information. | Thyroid eye disease Unverified catalogue summary (Treats) for Tepezza in US; not checked against current local product information. |
| Category | Eye Health Unverified catalogue summary (Category) for Vabysmo in US; not checked against current local product information. | Eye Health Unverified catalogue summary (Category) for Tepezza in US; not checked against current local product information. |
| Manufacturer | Genentech (Roche) Unverified catalogue summary (Manufacturer) for Vabysmo in US; not checked against current local product information. | Horizon Therapeutics Ireland DAC Unverified catalogue summary (Manufacturer) for Tepezza in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Vabysmo in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Tepezza in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Vabysmo in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Tepezza in US; not checked against current local product information. |
| Est. TV ad spend | $85M | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Vabysmo in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Tepezza in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Vabysmo or Tepezza better?
This directory does not compare clinical effectiveness or safety. Listing Vabysmo and Tepezza together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Vabysmo and Tepezza?
The table shows catalogue identification and estimated advertising information for Vabysmo and Tepezza, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Vabysmo has the larger estimated TV advertising budget of the two.